The paraneoplastic syndrome market is driven in part by the growing awareness and diagnosis of Paraneoplastic Neurologic Syndromes (PNS). PNS are a group of neurological disorders caused by an underlying cancer somewhere in the body. These disorders occur when the immune system, mistakenly triggered by the cancer, attacks the nervous system tissues. Symptoms of PNS can be diverse and...